Table 2.
Characteristics of studies included
Study | Study design | Participants included | Intervention and control | Location and study period | Follow-up | Patient-relevant outcomes |
---|---|---|---|---|---|---|
Carlson 2021a [18, 19] | Non-randomized prospective controlled trial, single centre | 166 |
sfSRS MR |
USA 2005–2019 |
2.1 years (mean) |
Facial palsy Hearing function Vertigo Headaches Tinnitus Balance function Adverse events Health-related quality of life |
Myrseth 2009 [20] | Non-randomized prospective controlled trial, single centre | 91 |
sfSRS MR |
Norway 2000–2007 |
2.0 years |
Mortality Facial palsy Hearing function Vertigo Tinnitus Balance function Work disability Adverse events Length of hospital stay Health-related quality of life |
Pollock 2006 [21] | Non-randomized prospective controlled trial, single centre | 82 |
sfSRS MR |
USA 2000–2002 |
42 months (mean) |
Facial palsy Hearing function Vertigo Headaches Adverse events Length of hospital stay Health-related quality of life |
MR microsurgical resection, sfSRS single-fraction stereotactic radiosurgery
athis is a 3-arm study. Data on the study arm with the treatment strategy of “watch and wait” are not presented